Want to join the conversation?
$BSX said it expects its full year 2016 adjusted R&D rate to be roughly 11.5%. This includes a 50 BP increase due to the reinvestment of the medical device tax, offset by increased efficiencies and improved utilization of the company's global footprint.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.